STAT3 and neoplasm: A recent study by Kumar and coworkers suggested that the inhibition of STAT3 activity is also associated with the pathological differentiation of M-MDSCs into TAMs, which were the major population within tumours compared to M-MDSC (Kumar et al. 2016a) indicating a level of unforseen complexity in the regulation of tumour immunity.